PCSA News and Press, Processa Pharmaceuticals Inc. From 01/29/24

2024-01-29 10:00:02 ET More on Health Care Select Sector SPDR Healthcare In 2024: Navigating The Biopharma Bull Run XLV Likely Back To Outperforming XLV: Considering The Low-Maintenance Option To Navigate The Healthcare Sector Investors were most bullish on H...

2024-01-29 08:22:54 ET Losers: Panbela Therapeutics PBLA -63% on $9M public offering . Aclarion ( ACON ) -19% . Corbus Pharmaceuticals Holdings ( CRBP ) -21% it releases data for ADC Tumor candidate . Richtech Robotics ( RR ) -11% . ...

Processa Pharmaceuticals (NASDAQ: PCSA) , a clinical-stage pharmaceutical company focused on developing the next generation of chemotherapeutic drugs to improve the efficacy and safety for more patients suffering from cancer, is announcing the pricing of its public offering. The offering is compr...

2024-01-26 09:33:10 ET More on Processa Pharmaceuticals Processa stock rallies on NGC-Cap development update Processa Pharmaceuticals to effect 1-for-20 reverse stock split to regain compliance with Nasdaq rule Seeking Alpha’s Quant Rating on Processa Pharmace...

2024-01-26 09:19:36 ET Losers: TC BioPharm ( TCBP ) -21% . Mobilicom Limited ( MOB ) -21% announces $2.95 Million registered direct offering . LAVA Therapeutics ( LVTX ) -14% . Evaxion Biotech ( EVAX ) -13% . Nxu ( NXU ) -13% ...

HANOVER, Md., Jan. 26, 2024 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage pharmaceutical company focused on developing the next generation of chemotherapeutic drugs to improve the efficacy and safety f...

2024-01-26 08:32:05 ET Losers: Aclarion ( ACON ) 119% . Panbela Therapeutics ( PBLA ) 59% . Processa Pharmaceuticals ( PCSA ) 29% . Corbus Pharmaceuticals Holdings ( CRBP ) 23% . as targeting antibody drug conjugate demonstrates encouragin...

2024-01-26 08:21:02 ET Aclarion ( ACON ) +113% . Panbela Therapeutics  ( PBLA ) +65% FORM S-1/A | Securities Registration Statement. TC BioPharm (Holdings)  ( TCBP ) +17% . Ucommune International  ( UK ) +17% . Processa Pharma...

2024-01-25 12:38:47 ET Gainers: Onconetix ( ONCO ) +161% . Processa Pharmaceuticals ( PCSA ) +109% . Rail Vision Ltd RVSN +78% . LAVA Therapeutics LVTX +38% . Vera Therapeutics VERA +38% . Prairie Operating Co PROP +29% . Clearmi...

2024-01-25 10:00:05 ET More on Health Care Select Sector SPDR Healthcare In 2024: Navigating The Biopharma Bull Run XLV Likely Back To Outperforming XLV: Considering The Low-Maintenance Option To Navigate The Healthcare Sector Investors were most bullish on H...